Thrombohemorrhagic complications of myeloproliferative disorders

被引：48

作者：

Papadakis, Emmanouil ^{[2
]}

Hoffman, Ron ^{[1
]}

Brenner, Benjamin ^{[1
]}

机构：

[1] Thrombosis & Hemostasis Unit, IL-31096 Haifa, Israel

[2] Pappagergiou Hosp, Dept Hematol, Thessaloniki, Greece

来源：

BLOOD REVIEWS | 2010年 / 24卷 / 06期

关键词：

SPLANCHNIC VEIN-THROMBOSIS; TYROSINE KINASE JAK2; BUDD-CHIARI-SYNDROME; ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; RISK-FACTORS; PROGNOSTIC-FACTORS; PLATELET COUNT; CLINICAL-FEATURES; ENDOTHELIAL-CELLS;

D O I：

10.1016/j.blre.2010.08.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Myeloproliferative disorders are commonly associated with thrombohemorrhagic manifestations The current review highlights recent advances in understanding the epidemiology and pathogenetic mechanisms of thrombotic and bleeding complications Therapeutic modalities and prophylactic interventions corresponding to the specific disease states are also discussed (C) 2010 Elsevier Ltd All rights reserved

引用

页码：227 / 232

页数：6

共 81 条

[1] Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: Relationship with splanchnic vein thrombosis and arterial disease [J].

Amitrano, L ;

Guardascione, MA ;

Ames, PRJ ;

Margaglione, M ;

Antinolfi, I ;

Iannaccone, L ;

Annunziata, M ;

Ferrara, F ;

Brancaccio, V ;

Balzano, A .

AMERICAN JOURNAL OF HEMATOLOGY, 2003, 72 (02) :75-81

[2] BUDD-CHIARI SYNDROME AND THROMBOSIS OF OTHER ABDOMINAL VESSELS IN THE CHRONIC MYELOPROLIFERATIVE DISEASES [J].

ANGER, BR ;

SEIFRIED, E ;

SCHEPPACH, J ;

HEIMPEL, H .

KLINISCHE WOCHENSCHRIFT, 1989, 67 (16) :818-825

[3]

BARBUI T, BLOOD, DOI DOI 10.1182/BLOOD.2009.08.238956

[4] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].

Baxter, EJ ;

Scott, LM ;

Campbell, PJ ;

East, C ;

Fourouclas, N ;

Swanton, S ;

Vassiliou, GS ;

Bench, AJ ;

Boyd, EM ;

Curtin, N ;

Scott, MA ;

Erber, WN ;

Green, AR .

LANCET, 2005, 365 (9464) :1054-1061

[5] Major vascular complications in essential thrombocythemia:: a study of the predictive factors in a series of 148 patients [J].

Besses, C ;

Cervantes, F ;

Pereira, A ;

Florensa, L ;

Solé, F ;

Hernández-Boluda, C ;

Woessner, S ;

Sans-Sabrafen, J ;

Rozman, C ;

Montserrat, E .

LEUKEMIA, 1999, 13 (02) :150-154

[6]

BUDDE U, 1993, BLOOD, V82, P1749

[7] THE INCIDENCE OF THROMBOTIC AND HEMORRHAGIC DISORDERS IN ASSOCIATION WITH EXTREME THROMBOCYTOSIS - AN ANALYSIS OF 129 CASES [J].

BUSS, DH ;

STUART, JJ ;

LIPSCOMB, GE .

AMERICAN JOURNAL OF HEMATOLOGY, 1985, 20 (04) :365-372

[8] Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status:: a prospective study [J].

Campbell, PJ ;

Scott, LM ;

Buck, G ;

Wheatley, K ;

East, CL ;

Marsden, JT ;

Duffy, A ;

Boyd, EM ;

Bench, AJ ;

Scott, MA ;

Vassiliou, GS ;

Milligan, DW ;

Smith, SR ;

Erber, WN ;

Bareford, D ;

Wilkins, BS ;

Reilly, JT ;

Harrison, CN ;

Green, AR .

LANCET, 2005, 366 (9501) :1945-1953

[9] Leukocytosis and risk stratification assessment in essential thrombocythemia [J].

Carobbio, Alessandra ;

Antonioli, Elisabetta ;

Guglielmelli, Paola ;

Vannucchi, Alessandro M. ;

Delaini, Federica ;

Guerini, Vittoria ;

Finazzi, Guido ;

Rambaldi, Alessandro ;

Barbui, Tiziano .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (16) :2732-2736

[10] Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status [J].

Carobbio, Alessandra ;

Finazzi, Guido ;

Guerini, Vittoria ;

Spinelli, Orietta ;

Delaini, Federica ;

Marchioli, Roberto ;

Borrelli, Giovanna ;

Rambaldi, Alessandro ;

Barbui, Tiziano .

BLOOD, 2007, 109 (06) :2310-2313

← 1 2 3 4 5 6 7 8 9 →